It takes pharma companies about five times longer to create content, compared to other industries. Delayed drug approvals turn into an average loss of $1 million dollars per day for pharma companies. Val Swisher and Regina Lynn Preciado from Content Rules recently published an interesting e-book: “Structured Content for Pharma – Making the Case for […]
Structured content for pharma Read More »
In pharma—and many other industries, too—Microsoft Word is the tool to create content. It’s the natural environment for many subject-matter experts to write, edit and review content. Every author is familiar with the Word interface. But it’s not structured content that’s created … “We cannot change the authoring experience” Forcing subject-matter experts, for example medical
Moving from Word: why changing the interface is unacceptable Read More »
Today, Jan Benedictus presented at the Global Pharmaceutical Regulatory Affairs Summit 2022 in Berlin: “The Future of Documents: Structured Content, Integrated Data”. Global Pharmaceutical Regulatory Affairs Summit The Global Pharmaceutical Regulatory Affairs Summit focuses on the challenges of IDMP, RIM, eSubmissions and Global Market Regulation in the pharmaceutical industry. The Future of Documents The Future
Global Pharmaceutical Regulatory Affairs Summit: Structured Content and Integrated Data Read More »
Earlier this year, Adobe commissioned Forrester Consulting to evaluate the role structured content management via a CCMS (component content management system) can play in addressing strategic and operational gaps. As a result, the report titled: ‘Component Content Management Systems: Supercharge Long-Form Content For Personalized And Consistent Experiences’ was published this August. XML-based authoring Since Fonto
Advantages of component based content management Read More »
In a very informative and recently published report by Outsell, lead analyst Tatiana Khayrullina confirms what Forrester described earlier in its ‘Future of Documents’ report: “Despite more than 30 years of mainstream use of office authoring tools, not much has changed. Increasingly, enterprises deliver documents to customers in forms that aren’t fit for purpose. The
Moving from documents to data in the Standards Publishing industry Read More »
At Fonto, our mission is to open up structured content authoring (SCA) for anyone. By doing so, we help organizations make the strategic shift from traditional documents to structured content. We help them by engaging the people who are the most important stakeholders in any authoring process: the authors. Fonto allows users to write, edit
The Future of Documents: the Fonto perspective Read More »
“Despite more than 30 years of mainstream use of office authoring tools, not much has changed. Increasingly, enterprises deliver documents to customers in forms that aren’t fit for purpose. The next decade will reveal new cloud-native, data-driven, and structured approaches to document authoring.” Forrester, The Future Of Documents, December 2020. Wow! At Fonto we fell
Moving from documents to data Read More »
If you think it’s hard to explain something like TikTok to your 94-year-old grandmother, try explaining the subject of ‘structured content’ to your friends. It’s a struggle for all of us at Fonto. So here’s another try to shed some light on the likes of structured content and the way we make it possible for
Structured content explained Read More »
During the 2019 AMPLEXOR ‘Be The Expert’ meeting, we had the pleasure to present our views on the potential of structured content authoring for the Life Sciences industry. We did so by comparing the adoption of ‘structured content’ in Life Sciences with the state of adoption in other industries. We notably compared Life Sciences with
Structured content: Life Sciences vs. other industries Read More »
How FontoXML helps pharmaceutical companies comply with future legislation In Pharma and Life Sciences structured content, or rather structured data, is a hot topic. Most, if not all companies in this industry are in the process of undertaking a multi-year cross-functional program to enable sustainable compliance with the upcoming IDMP requirements and to improve regulatory
IDMP and the need for structured authoring Read More »
